JFL Life Sciences Ltd
Fri 9/10/2026,12:40:25 | NSE : JFLLIFE
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 0.00
Previous Close
₹ 10.25
Volume
0
Mkt Cap ( ₹ Cr)
₹ 67.64
High
₹ 0.00
Low
₹ 0.00
52 Week High
₹ 14.45
52 Week Low
₹ 8.55
Book Value Per Share
₹ 12.12
Dividend Yield
₹ 0.00
Face Value
₹₹10.00
What's Your Call?
Collective community sentiment on JFL Life Sciences Ltd
Your Vote -
Buy
80.00%
Hold
0.00%
Sell
20.00%
80.00%
5 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
100%
Sell Order Quantity
0%
Bid Price
Qty
18.25
6000
18.00
6000
17.00
6000
17.00
6000
17.00
6000
Bid Total
36000
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts JFL Life Sciences Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
JFL Life Sciences has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2026
-
JFL Life Sciences - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
JFL Life Sciences - Trading Window
-
JFL Life Sciences - Appointment
-
JFL Life Sciences - Appointment
-
JFL Life Sciences - Appointment
-
JFL Life Sciences - Appointment
-
JFL Life Sciences - General Updates
-
JFL Life Sciences - Shareholders meeting
-
JFL Life Sciences - Shareholders meeting
-
JFL Life Sciences - Copy of Newspaper Publication
-
JFL Life Sciences - Outcome of Board Meeting
-
JFL Life Sciences - Copy of Newspaper Publication
-
JFL Life Sciences - Shareholders meeting
Key fundamentals
Evaluate the intrinsic value of JFL Life Sciences Ltd stockÂ
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 67.598 | 50.0456 | 41.2677 | 39.45 | 27.14 |
| Liabilities | 67.598 | 50.0456 | 41.2677 | 39.45 | 27.14 |
| Equity | 32.9953 | 32.9953 | 10.9984 | 11 | 8.02 |
| Gross Profit | 11.7111 | 8.199 | 4.545 | 3.93 | 5.36 |
| Net Profit | 6.401 | 4.1577 | 3.3079 | 2.81 | 2.81 |
| Cash From Operating Activities | -4.3307 | -3.5315 | 8.3572 | -9.05 | 2.32 |
| NPM(%) | 4.87 | 5.06 | 7.1 | 6.56 | 8.36 |
| Revenue | 131.3826 | 82.0423 | 46.5479 | 42.83 | 33.59 |
| Expenses | 119.6715 | 73.8433 | 42.0029 | 38.9 | 28.23 |
| ROE(%) | 8 | 5.19 | 4.13 | 3.51 | 3.51 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to JFL Life Sciences Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 791.10 | -0.35 | 20.01 | 0.00 | -26.19 | 0.63 |
| Lotus Eye Hospital and Institute Ltd | 114.10 | 0.14 | 1630.00 | 0.00 | 0.39 | 0.00 |
| Vaishali Pharma Ltd | 8.00 | 0.13 | 25.00 | 0.00 | 15.42 | 0.00 |
| Astec Lifesciences Ltd | 727.60 | 1.80 | 0.00 | 0.00 | -363.14 | 0.00 |
Company Info
The Company was incorporated as `JFL Life Sciences Private Limited' on April 25, 2010 as a private limited company under the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Pursuant to a special resolution of our Shareholders passed in the extra-ordinary general meeting held on February 10, 2022, the Company was converted from a private limited company to public limited company and consequently, the name of the Company was changed to `JFL Life Sciences Limited', and a fresh certificate of incorporation dated March 3, 2022 was issued t0 o our Company by the Registrar of Companies, Gujarat at Ahmedabad. The corporate identification number of our Company is U24230GJ2010PLC060417.Major Events and Milestones:2010 -Company was incorporated as a private limited company under the name JFL Life Sciences Private Limited2022 -Company was converted from a private limited company to a public limited company and its name was changed to JFL Life Sciences Limited. 2024-The Company has issued Bonus Shares in the Ratio of 2:1.
The Company was incorporated as `JFL Life Sciences Private Limited' on April 25, 2010 as a private limited company under the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Pursuant to a special resolution of our Shareholders passed in the extra-ordinary general meeting held on February 10, 2022, the Company was converted from a private limited company to public limited company and consequently, the name of the Company was changed to `JFL Life Sciences Limited', and a fresh certificate of incorporation dated March 3, 2022 was issued t0 o our Company by the Registrar of Companies, Gujarat at Ahmedabad. The corporate identification number of our Company is U24230GJ2010PLC060417.Major Events and Milestones:2010 -Company was incorporated as a private limited company under the name JFL Life Sciences Private Limited2022 -Company was converted from a private limited company to a public limited company and its name was changed to JFL Life Sciences Limited. 2024-The Company has issued Bonus Shares in the Ratio of 2:1.
Read More
Parent Organisation
JFL Life Sciences Ltd.
Founded
25/04/2010
Managing Director
Mr.Smiral Ashwinkumar Patel
NSE Symbol
JFLLIFESM
FAQ
The current price of JFL Life Sciences Ltd is
The 52-week high for JFL Life Sciences Ltd is
The market capitalization of JFL Life Sciences Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy JFL Life Sciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in JFL Life Sciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase JFL Life Sciences Ltd shares.
The CEO of JFL Life Sciences Ltd is Mr.Smiral Ashwinkumar Patel, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
